Share This Page
Drug Price Trends for AMOX-CLAV ER
✉ Email this page to a colleague
Average Pharmacy Cost for AMOX-CLAV ER
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| AMOX-CLAV ER 1,000-62.5 MG TAB | 00781-1943-82 | 5.80141 | EACH | 2025-03-19 |
| AMOX-CLAV ER 1,000-62.5 MG TAB | 00781-1943-39 | 5.80141 | EACH | 2025-03-19 |
| AMOX-CLAV ER 1,000-62.5 MG TAB | 00781-1943-82 | 5.72265 | EACH | 2025-02-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Amoxicillin-Clavulanate (AMOX-CLAV) Extended Release
Market Overview
The global market for amoxicillin-clavulanate, particularly the extended-release (ER) formulation, is experiencing significant growth driven by several key factors.
Increasing Prevalence of Bacterial Infections
The rising incidence of bacterial infections worldwide is a major driver for the demand of amoxicillin-clavulanate. This includes infections such as respiratory tract infections, skin infections, and urinary tract infections, which are becoming more common due to factors like global travel, antimicrobial resistance, and climate change[4].
Expanding Healthcare Infrastructure
The growth in healthcare infrastructure, especially in emerging economies, is enhancing the accessibility and availability of antibiotics like amoxicillin-clavulanate. This expansion is supported by increased healthcare expenditure, which benefits the market by ensuring wider prescription rates and improved patient outcomes[4].
Innovative Formulations and Delivery Mechanisms
The introduction of innovative formulations, such as extended-release tablets and injectable solutions, is contributing to the market's growth. These formulations offer enhanced convenience and improved patient compliance, making them more appealing to both healthcare providers and patients[1].
Market Size and Growth Projections
- The global amoxicillin market, which includes amoxicillin-clavulanate, is projected to grow steadily. It is expected to increase from $4.58 billion in 2023 to $4.74 billion in 2024, with a compound annual growth rate (CAGR) of 3.4%. By 2028, the market is anticipated to reach $5.44 billion, and by 2033, it is expected to continue growing[4].
- The extended-release formulation, specifically, is expected to hold a significant share due to its convenience and ease of administration. The oral dosage form, which includes extended-release tablets, is projected to dominate the market due to its high penetration in healthcare settings[1].
Regional Analysis
- Asia-Pacific: This region is expected to dominate the global amoxicillin market, including the extended-release formulation, due to the high incidence of infectious diseases and expanding healthcare infrastructure in countries like China and India[1][3].
- North America: This region also holds a significant share, driven by the prevalence of respiratory infections and advanced healthcare facilities[3].
Pricing and Cost Analysis
- The cost of amoxicillin-clavulanate extended-release tablets can vary depending on the pharmacy and location. For example, a supply of 28 tablets of Augmentin XR (1000 mg-62.5 mg) can cost around $204 to $210, depending on the pharmacy[2][5].
- Generic versions of amoxicillin-clavulanate are also available, which can significantly reduce the cost. For instance, a generic version of amoxicillin-clavulanate (1000 mg-62.5 mg) can cost around $116 for 28 tablets[2].
Competitive Landscape
- The market is highly competitive, with key players such as United Laboratories, Sun Pharma, CSPC, and others actively involved in research and development to enhance the efficacy and safety of amoxicillin-clavulanate. Strategic collaborations and mergers are common among these players to expand their market presence[1].
- Companies like Centrient Pharmaceuticals, Wockhardt Limited, and Ranbaxy Laboratories Ltd. are also developing innovative drugs and formulations to improve patient outcomes[4].
Trends and Strategies
- Combination Therapies: There is a growing focus on combination therapies that include amoxicillin-clavulanate, which are more effective against a broader range of bacterial infections[4].
- Antibiotic Stewardship: Efforts to combat antibiotic resistance are driving the development of targeted antibiotics with reduced resistance potential. This includes advancements in personalized medicine for antibiotic selection and the use of artificial intelligence in antibiotic discovery and development[1][4].
- Immunotherapy and Probiotics: There is an increasing interest in immunotherapy and probiotics as complementary treatments to antibiotics, which could impact the market dynamics in the future[4].
Impact of Regulations
- The market is influenced by stringent regulatory requirements for antibiotic approval and manufacturing. Antibiotic resistance monitoring and stewardship programs are also crucial in shaping the market[1].
End User Concentration
- Healthcare providers, hospitals, and clinics account for the majority of the consumption of amoxicillin-clavulanate. There is also an increasing use in animal health and agriculture, which adds to the overall demand[1].
Key Takeaways
- The global amoxicillin-clavulanate market, including the extended-release formulation, is expected to grow significantly due to increasing bacterial infections and expanding healthcare infrastructure.
- Innovative formulations and delivery mechanisms are enhancing patient compliance and driving market growth.
- The Asia-Pacific region is expected to dominate the market, while North America will also remain a significant player.
- Pricing varies, but generic versions can significantly reduce costs.
- The market is competitive, with key players focusing on research and development and strategic collaborations.
FAQs
What are the primary drivers of the amoxicillin-clavulanate market?
The primary drivers include the increasing prevalence of bacterial infections, expanding healthcare infrastructure, and the introduction of innovative formulations and delivery mechanisms.
How does the cost of amoxicillin-clavulanate extended-release tablets vary?
The cost can vary depending on the pharmacy and location, but generic versions can significantly reduce the cost, with prices ranging from $116 to $210 for a supply of 28 tablets.
Which region is expected to dominate the global amoxicillin market?
The Asia-Pacific region is expected to dominate the market due to the high incidence of infectious diseases and expanding healthcare infrastructure.
What are the key trends in the amoxicillin-clavulanate market?
Key trends include a focus on combination therapies, antibiotic stewardship, and the use of artificial intelligence in antibiotic discovery and development.
Who are the major players in the amoxicillin-clavulanate market?
Major players include United Laboratories, Sun Pharma, CSPC, Centrient Pharmaceuticals, Wockhardt Limited, and Ranbaxy Laboratories Ltd.
Sources
- Data Insights Market: Amoxicillin Antibiotic Report: Trends and Forecasts 2025-2033
- Drugs.com: Augmentin XR Prices, Coupons, Copay Cards & Patient Assistance
- Data Bridge Market Research: Global Amoxicillin Market – Industry Trends and Forecast to 2029
- GlobeNewswire: Amoxicillin Market Research Report 2024: Combination Therapies and Immunotherapy Trends Shaping Future Landscape
- Drugs.com: Amoxicillin/clavulanate Prices, Coupons, Copay Cards & Patient Assistance
More… ↓
